BPTF and non-small cell lung carcinoma: Xu et al. have shown in non-small cell lung cancer promising results with the specific BPTF inhibitor C620-0696 design to target the bromodomain [43] and Lu et al. have designed two new BPTF-inhibitors, namely DC-BPi-07 and DC-BPi-11, with therapeutic potential in MV-4-11 leukaemia cells [44].